Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F2Q1V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,404
Award facts
- Contract value 100% obligated
- $11,404.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,404.40 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count). This firm fixed-price contract, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, through its parent organization Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. The company maintains established procurement relationships with DLA for a diverse portfolio of medications across multiple therapeutic domains. This specific delivery order for Otezla, a psoriasis and rheumatoid arthritis treatment, exemplifies the routine pharmaceutical supply operations conducted under the broader master contract vehicle, ensuring consistent availability of brand-name and generic medications to support federal military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F2Q1V?
SPE2DR26F2Q1V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F2Q1V worth?
The government has obligated $11,404 on SPE2DR26F2Q1V.
Is contract SPE2DR26F2Q1V an order under another contract?
Yes. SPE2DR26F2Q1V is a delivery order under SPE2DR25D3102, an indefinite delivery contract.
Was contract SPE2DR26F2Q1V competed?
The extent of competition for SPE2DR26F2Q1V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award